On 27 November 2025, the SPOG General Assembly elected the Board of Directors for the next three years.
We are pleased to announce that all current Board members have been confirmed in their positions. In addition, two new members will join the committee as of 1 January 2026.
President
Prof. Dr. med. Katrin Scheinemann, Medical Director Centre for Haematology/ Oncology of the East Switzerland Children’s Hospital St. Gallen (SPOG President since 2020)
Vice President
PD Dr. med. Nicolas Gerber, Senior Consultant in Paediatric Oncology at the University Children’s Hospital Zurich (SPOG Vice President since 2020)
Members
PD Dr. med. Tamara Diesch-Furlanetto, Deputy Head of Department and Senior Consultant in Haematology and Oncology at the University Children’s Hospital of Basel UKBB (from 2026)
Dr. med. Daniel Drozdov, Deputy Senior Consultant in Paediatric Haematology and Oncology at KSA Children’s Hospital Aarau (from 2026)
Prof. Dr. med. Dr. phil. Raffaele Renella, Head of the Department of Paediatric Haematology-Oncology at University Hospital Lausanne CHUV (since 2022)
PD Dr. med. Dr. sc. nat. André von Büren, Senior Consultant Division of Paediatric Haematology and Oncology at University Hospitals Geneva HUG (since 2022)
We warmly congratulate the re-elected President and Vice President as well as all Board members and wish them every success for the upcoming term.
Catia Gehrig
Catia Gehrig is Head Partner Relations at SPOG and is responsible for communications, fundraising and administration. She is a passionate communicator and networker for paediatric cancer research.
More articles from Catia Gehrig
